Stable liquid pharmaceutical preparation
AssigneeCelltrion Inc.
InventorsJoon Won Lee, Won Yong Han, Su Jung Kim, Jun Seok Oh, So Young Kim, Su Hyeon Hong, Yeon Kyeong Shin
Life of this patent
Estimating the term…
Abstract
The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.
Claims14
A stable liquid pharmaceutical formulation, comprising:
- (A) 90 to 145 mg/ml of infliximab;
- (B) 0.02 to 0.1% (w/v) of a surfactant comprising polysorbate 80;
- (C) 1 to 10% (w/v) of a sugar comprising sorbitol;
- and
- (D) 1 to 50 mM of a buffer comprising sodium acetate.
Dependencies are inferred from the claim text.